Facebook Linkedin RSS Twitter Youtube
Home 2024

NanoString Technologies

Aiming High: 10x, NanoString Launch Large-Scale Panels
GEN Edge

Aiming High: 10x, NanoString Launch Large-Scale Panels

Court Grants Vizgen Motion to Expand Antitrust Case vs.10x, Harvard
GEN Edge

Court Grants Vizgen Motion to Expand Antitrust Case vs.10x, Harvard

Bruker to Acquire NanoString with $392.6M Winning Bid
GEN Edge

Bruker to Acquire NanoString with $392.6M Winning Bid

As 10x Launches Visium HD, Will Single Cell Resolution Draw New Customers?
GEN Edge

As 10x Launches Visium HD, Will Single Cell Resolution Draw New Customers?

10x Defends Patent Litigation Strategy after Criticism from Researchers, Rivals
GEN Edge

10x Defends Patent Litigation Strategy after Criticism from Researchers, Rivals

NanoString Finds a Buyer, Slide Tags Enter in Early Access as Curio Trekker, Cellares Unveils Cell Therapy Manufacturing Platform
Bioprocessing

NanoString Finds a Buyer, Slide Tags Enter in Early Access as Curio Trekker, Cellares Unveils Cell Therapy Manufacturing Platform

NanoString Agrees to be Acquired by Investment Firm for $220M
GEN Edge

NanoString Agrees to be Acquired by Investment Firm for $220M

Intellia and Ultragenyx’s Clinical Updates, Novo Holdings’ Catalent Acquisition, and NanoString Bankruptcy; Simon Barnett
Bioprocessing

Intellia and Ultragenyx’s Clinical Updates, Novo Holdings’ Catalent Acquisition, and NanoString Bankruptcy; Simon Barnett

At AGBT, 10x Genomics Launches Next-Generation Single Cell Architecture
GEN Edge

At AGBT, 10x Genomics Launches Next-Generation Single Cell Architecture

NanoString CSO Joe Beechem Insists the Company “Not Going Anywhere”
Industry News

NanoString CSO Joe Beechem Insists the Company “Not Going Anywhere”

123Page 1 of 3
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.